
Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer
Keywords: Polyamidoamine; Erlotinib; Survivin; Chloroquine; EGFR; NSCLC;